Cargando…
Alzheimer’s disease: natural products as inhibitors of neuroinflammation
Alzheimer’s disease (AD) is the most common form of dementia and affects 44 million people worldwide. New emerging evidence from pre-clinical and clinical investigations shows that neuroinflammation is a major pathological component of AD suggesting that anti-inflammatory strategies are important in...
Autores principales: | Olajide, Olumayokun A., Sarker, Satyajit D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7572326/ https://www.ncbi.nlm.nih.gov/pubmed/32930914 http://dx.doi.org/10.1007/s10787-020-00751-1 |
Ejemplares similares
-
Induction of Neuroinflammation and Neurotoxicity by Synthetic Hemozoin
por: Velagapudi, Ravikanth, et al.
Publicado: (2019) -
Nimbolide Targets Multiple Signalling Pathways to Reduce Neuroinflammation in BV-2 Microglia
por: Katola, Folashade O., et al.
Publicado: (2023) -
Neuroprotection by Skimmianine in Lipopolysaccharide-Activated BV-2 Microglia
por: Ogunrinade, Folashade A., et al.
Publicado: (2023) -
Inhibition of Neuroinflammation in LPS-Activated Microglia by Cryptolepine
por: Olajide, Olumayokun A., et al.
Publicado: (2013) -
SARS-CoV-2 Spike Glycoprotein S1 Induces Neuroinflammation in BV-2 Microglia
por: Olajide, Olumayokun A., et al.
Publicado: (2021)